Breaking News Instant updates and real-time market news.

TWNK

Hostess Brands

$15.19

-0.14 (-0.91%)

, CRTO

Criteo

$51.42

-0.03 (-0.06%)

10:17
07/31/17
07/31
10:17
07/31/17
10:17

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hostess Brands (TWNK) initiated with a Neutral at UBS. 2. Criteo (CRTO) coverage resumed with an Overweight at KeyBanc. 3. CMS Energy (CMS) initiated with an Equal Weight at Morgan Stanley. 4. AxoGen (AXGN) initiated with an Outperform at Leerink. 5. Covanta (CVA) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TWNK

Hostess Brands

$15.19

-0.14 (-0.91%)

CRTO

Criteo

$51.42

-0.03 (-0.06%)

CMS

CMS Energy

$46.27

-0.03 (-0.06%)

AXGN

AxoGen

$15.10

-0.5 (-3.21%)

CVA

Covanta

$14.75

0.35 (2.43%)

  • 02

    Aug

  • 08

    Aug

  • 09

    Aug

  • 15

    Aug

TWNK Hostess Brands
$15.19

-0.14 (-0.91%)

07/31/17
UBSW
07/31/17
INITIATION
Target $16
UBSW
Neutral
Hostess Brands initiated with a Neutral at UBS
UBS analyst Steven Strycula started Hostess Brands with a Neutral rating and $16 price target. Decelerating industry trends and elevated consensus earnings expectations leave a balanced risk/reward profile, the analyst contends.
05/16/17
SPHN
05/16/17
INITIATION
Target $20
SPHN
Overweight
Hostess Brands initiated with an Overweight at Stephens
Stephens analyst Farha Aslam initiated Hostess Brands with an Overweight rating and $20 price target.
05/10/17
DBAB
05/10/17
NO CHANGE
Target $19
DBAB
Buy
Hostess Brands FCF yield offers buying opportunity, says Deutsche Bank
Deutsche Bank analyst Rob Dickerson believes Hostess Brands' free cash yield presents a buying opportunity. The company's Q1 results came in at the high end of pre-released revenue and EBITDA, full-year guidance was held, and continued category share gains are expected, Dickerson tells investors in a post-earnings research note. The analyst keeps a Buy rating on Hostess with a $19 price target.
03/15/17
DBAB
03/15/17
NO CHANGE
Target $19
DBAB
Buy
Deutsche still views Hostess favorably following Q4 results
Deutsche Bank analyst Rob Dickerson raised his price target for Hostess Brands shares to $19 from $18 following the company's "strong" Q4 results. A 13% sales gain and gross margin expansion led the quarter, Dickerson tells investors in a research note. He continues to view Hostess favorably with a Buy rating.
CRTO Criteo
$51.42

-0.03 (-0.06%)

07/31/17
KEYB
07/31/17
INITIATION
KEYB
Overweight
Criteo coverage resumed with an Overweight at KeyBanc
KeyBanc analyst Andy Hargreaves resumed coverage of Criteo with a $62 price target and an Overweight rating. The analyst says that the company's "large scale" and "focus on performance marketing" help protect it from competition. He expects the company's profits to grow more than 20% annually and thinks that it has multiple positive catalysts, including international growth, increased spending by its current customers, and "expansion into acquisition marketing."
06/06/17
JEFF
06/06/17
NO CHANGE
Target $66
JEFF
Buy
Criteo selloff on Apple news a buying opportunity, says Jefferies
Jefferies analyst Brian Fitzgerald notes Criteo (CRTO) yesterday traded down 7% on news that the newest version of Apple's (AAPL) desktop Safari web browser would attempt to curtail re-targeted ads. The selloff is a "clear overreaction" as Safari likely accounts for less than 1.5% of Criteo's revenue, Fitzgerald tells investors in a research note. The company's business is already "quickly mix-shifting" away from desktop browsers and away from Safari specifically, the analyst adds. He recommends using yesterday's pullback as a buying opportunity and keeps a Buy rating on Criteo with a $66 price target.
06/08/17
RBCM
06/08/17
NO CHANGE
RBCM
Criteo says Safari desktop accounts for under 3% of revenue, says RBC Capital
After meeting with Criteo's (CRTO) CFO, RBC Capital analyst Mark Mahaney quotes the company as saying that its understanding is that Apple's (AAPL) ad blocking initiative so far only applies to the desktop version of its Safari browser. Criteo reported that it obtains less than 3% of its revenue ex TAC from that source, Mahaney wrote. Criteo also believes that the new feature will not block tracking until the user is on the browser for a certain amount of time. Mahaney says that Criteo has proven adept at adjusting to changing conditions in the past. He keeps a $60 price target and Outperform rating on the stock.
06/06/17
COWN
06/06/17
NO CHANGE
Target $60
COWN
Outperform
Criteo stock reaction after Apple developer conference overdone, says Cowen
Cowen analyst Thomas Champion noted Criteo (CRTO) shares were under pressure following comments from the Apple (AAPL) developer conference yesterday, but he believes exposure to the desktop Safari browser seems limited, which will mitigate risk to revenue, suggesting the stock reaction is overdone. Champion reiterated his Outperform rating on Criteo shares.
CMS CMS Energy
$46.27

-0.03 (-0.06%)

07/31/17
MSCO
07/31/17
INITIATION
Target $47
MSCO
Equal Weight
CMS Energy initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Stephen Byrd initiated CMS Energy with an Equal Weight and a $47 price target saying valuation reflects strong execution.
03/06/17
EVER
03/06/17
UPGRADE
Target $45.5
EVER
Outperform
CMS Energy upgraded to Outperform from In Line at Evercore ISI
Evercore ISI analyst Greg Gordon upgraded CMS Energy to Outperform from In Line as he believes the company deserves a premium valuation based on what he views as its "superior" EPS and dividend growth outlook. He raised his price target on the stock to $45.50 from $44.50.
01/30/17
UBSW
01/30/17
UPGRADE
UBSW
Buy
CMS Energy upgraded to Buy from Neutral at UBS
07/24/17
FBCO
07/24/17
UPGRADE
Target $50
FBCO
Outperform
CMS Energy upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Michael Weinstein upgraded CMS Energy to Outperform from Neutral after recent underperformance. The analyst also raised his price target on the shares to $50 from $48.
AXGN AxoGen
$15.10

-0.5 (-3.21%)

06/29/17
CANT
06/29/17
INITIATION
Target $18
CANT
Overweight
AxoGen initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Travis Steed started AxoGen with an Overweight rating and $18 price target.
11/22/16
LSCM
11/22/16
UPGRADE
Target $11
LSCM
Buy
AxoGen upgraded to Buy from Hold at Lake Street
Lake Street analyst Bruce Jackson upgraded AxoGen to Buy saying the "story is revived' following yesterday's analyst meeting. The company unveiled a new product for adhesion prevention called Avive along with two other pipeline development programs in breast reconstruction and lower limb iatrogenic nerve injury, Jackson tells investors in a research note. The analyst raised his price target for the shares to $11 from $9.
07/31/17
LEER
07/31/17
INITIATION
Target $22
LEER
Outperform
AxoGen initiated with an Outperform at Leerink
Leerink analyst Richard Newitter started AxoGen with an Outperform rating and $22 price target. The company is well positioned to sustain a leading position in peripheral nerve repair, the analyst contends.
03/06/17
ROTH
03/06/17
INITIATION
Target $14.5
ROTH
Buy
AxoGen initiated with a Buy at Roth Capital
Roth Capital analyst Chris Lewis started AxoGen with a Buy rating and $14.50 price target as he believes it is well-positioned to continue expanding the treatment algorithms of surgeons to include all of its products across its full treatment continuum in peripheral nerve repair.
CVA Covanta
$14.75

0.35 (2.43%)

07/31/17
STFL
07/31/17
UPGRADE
STFL
Buy
Covanta upgraded to Buy from Hold at Stifel
07/31/17
STFL
07/31/17
UPGRADE
STFL
Buy
Covanta upgraded on cost controls, increased visibility at Stifel
As noted earlier, Stifel upgraded Covanta to Buy from Hold. As reasons for the upgrade, analyst Michael Hoffman cited increased cost controls, stronger visibility of its AEBITDA and free cash flow growth, and WTE development opportunities in the U.K. Target to $17 from $15.50.
07/31/17
BMOC
07/31/17
UPGRADE
BMOC
Outperform
Covanta upgraded on free cash flow outlook at BMO Capital
As noted earlier, BMO Capital upgraded Covanta to Outperform from Market Perform. Analyst Jeffrey Silber says that the company's "path to positive free cash flow improvement" has become "more apparent given results to date and strong dynamics in the waste market." Target to $17 from $16.
07/31/17
BMOC
07/31/17
INITIATION
BMOC
Outperform
Covanta initiated with an Outperform at BMO Capital

TODAY'S FREE FLY STORIES

SD

SandRidge Energy

$17.50

0.88 (5.29%)

, BCEI

Bonanza Creek

$32.14

0.46 (1.45%)

16:44
11/22/17
11/22
16:44
11/22/17
16:44
Hot Stocks
Icahn reports 13.51% stake in SandRidge Energy, intends to vote against Bonanza »

Icahn has read Fir Tree…

SD

SandRidge Energy

$17.50

0.88 (5.29%)

BCEI

Bonanza Creek

$32.14

0.46 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$17.50

0.88 (5.29%)

16:35
11/22/17
11/22
16:35
11/22/17
16:35
Hot Stocks
Icahn reports 13.51% stake in SandRidge Energy, intends to vote against Bonanza »

Icahn agrees with Fir…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$28.43

0.32 (1.14%)

, AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

16:32
11/22/17
11/22
16:32
11/22/17
16:32
Hot Stocks
Symantec selects Amazon Web Services to deliver cloud security »

Amazon Web Services, an…

SYMC

Symantec

$28.43

0.32 (1.14%)

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 18

    Mar

16:30
11/22/17
11/22
16:30
11/22/17
16:30
Options
Preliminary option volume of 13.6M today »

Preliminary option volume…

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

16:26
11/22/17
11/22
16:26
11/22/17
16:26
Hot Stocks
Amazon Web Services announces Amazon ML Solutions Lab program »

Amazon Web Services, Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

NRIM

Northrim BanCorp

$34.75

-0.25 (-0.71%)

16:22
11/22/17
11/22
16:22
11/22/17
16:22
Hot Stocks
Northrim BanCorp announces CFO transition »

Northrim BanCorp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

, CERN

Cerner

$70.03

3.35 (5.02%)

16:21
11/22/17
11/22
16:21
11/22/17
16:21
General news
On The Fly: Top stock stories for Wednesday »

Stocks opened in positive…

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

CERN

Cerner

$70.03

3.35 (5.02%)

HPE

HP Enterprise

$13.10

-1.02 (-7.22%)

HPQ

HP Inc.

$21.34

-1.12 (-4.99%)

DE

Deere

$145.25

6.02 (4.32%)

ROK

Rockwell Automation

$191.02

-2 (-1.04%)

EMR

Emerson

$61.88

1.53 (2.54%)

AKZOY

AkzoNobel

$31.04

0.475 (1.55%)

AXTA

Axalta Coating

$35.50

1.63 (4.81%)

GME

GameStop

$17.37

0.64 (3.83%)

GES

Guess

$15.62

-2.33 (-12.98%)

IRBT

iRobot

$68.50

-4.57 (-6.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 11

    Dec

  • 18

    Mar

CHMI

Cherry Hill Mortgage

$18.51

0.06 (0.33%)

16:21
11/22/17
11/22
16:21
11/22/17
16:21
Syndicate
Breaking Syndicate news story on Cherry Hill Mortgage »

Cherry Hill Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$49.75

-0.23 (-0.46%)

16:20
11/22/17
11/22
16:20
11/22/17
16:20
Hot Stocks
Nektar names new CRDO, CMO and CSO »

Nektar announced several…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
11/22/17
11/22
16:20
11/22/17
16:20
Options
Closing CBOE SPX and VIX Index summary for November 22nd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGZ

Vista Gold

$0.68

0.0069 (1.03%)

16:18
11/22/17
11/22
16:18
11/22/17
16:18
Syndicate
Vista Gold enters $10M ATM agreement with H.C. Wainwright & Co. »

Vista Gold announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPX

GP Strategies

$23.50

-0.2 (-0.84%)

16:17
11/22/17
11/22
16:17
11/22/17
16:17
Hot Stocks
GP Strategies announces $10M share repurchase increase »

GP Strategies Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

$NSD

NASDAQ Market Internals

16:17
11/22/17
11/22
16:17
11/22/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPX

GP Strategies

$23.50

-0.2 (-0.84%)

16:16
11/22/17
11/22
16:16
11/22/17
16:16
Hot Stocks
GP Strategies names Michael Dugan as new CFO »

Global performance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

$NYE

NYSE Market Internals

16:16
11/22/17
11/22
16:16
11/22/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPP

FieldPoint Petroleum

$0.25

-0.015 (-5.77%)

16:13
11/22/17
11/22
16:13
11/22/17
16:13
Hot Stocks
FieldPoint Petroleum to be suspended, pending delisting from NYSE American »

FieldPoint Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVA

Avista

$51.70

0.145 (0.28%)

16:12
11/22/17
11/22
16:12
11/22/17
16:12
Hot Stocks
Avista names Kevin Christie CCO, Dennis Vermillion President »

Avista announced changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWBR

CohBar, Inc.

16:11
11/22/17
11/22
16:11
11/22/17
16:11
Syndicate
Breaking Syndicate news story on CohBar, Inc. »

CohBar, Inc. files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTBX

Heat Biologics

$0.44

-0.0045 (-1.01%)

16:08
11/22/17
11/22
16:08
11/22/17
16:08
Syndicate
Heat Biologics requests withdrawal of registration statement »

The company is requesting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$14.65

0.16 (1.10%)

16:06
11/22/17
11/22
16:06
11/22/17
16:06
Hot Stocks
TimkenSteel and United Steelworkers reach tentative four-year agreement »

TimkenSteel and the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMNB

American National Bankshares

$39.00

-0.5 (-1.27%)

16:06
11/22/17
11/22
16:06
11/22/17
16:06
Hot Stocks
American National Bankshares raises quarterly dividend to 25c from 24c »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$34.10

0.09 (0.26%)

16:04
11/22/17
11/22
16:04
11/22/17
16:04
Periodicals
BMW to recall all i3 electric vehicles, Automotive News reports »

BMW will recall all i3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVA

DaVita

$55.20

0.03 (0.05%)

16:04
11/22/17
11/22
16:04
11/22/17
16:04
Periodicals
DaVita exploring sale of DaVita Medical Group business, Reuters says »

DaVita is exploring a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGC

Peapack-Gladstone

16:02
11/22/17
11/22
16:02
11/22/17
16:02
Hot Stocks
Peapack-Gladstone's Chief Strategy Officer and General Counsel departing »

Peapack-Gladstone's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$104.90

-0.67 (-0.63%)

15:50
11/22/17
11/22
15:50
11/22/17
15:50
Options
VanEck Vectors Semiconductor Fund sees notable put buying »

VanEck Vectors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.